| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | 204,1 k € | — | — | 217,5 k € | +4.5% | 208,1 k € | — | 207,2 k € | +16.1% | 178,5 k € | +13.5% | 157,3 k € | +7.5% | 146,3 k € | +12.8% | 129,7 k € | -29.2% | 183,3 k € | ||||||||||
| Gross margin | 172,8 k € | +4.7% | 165,1 k € | +12.1% | 147,3 k € | +9.8% | 134,1 k € | +80.4% | 74,3 k € | -33.6% | 111,9 k € | +29.0% | 86,8 k € | -8.8% | 95,2 k € | -1.1% | 96,3 k € | +30.4% | 73,9 k € | -22.9% | 95,8 k € | +31.8% | 72,7 k € | -23.7% | 95,2 k € | +13.5% | 83,9 k € | +19.0% | 70,5 k € | -48.2% | 136,1 k € | |
| EBITDA | 172,0 k € | +4.9% | 164,0 k € | +11.9% | 146,5 k € | +12.1% | 130,8 k € | +78.8% | 73,1 k € | -34.1% | 110,9 k € | +29.0% | 86,0 k € | -8.7% | 94,2 k € | +0.5% | 93,8 k € | +29.7% | 72,3 k € | -23.4% | 94,4 k € | +32.2% | 71,4 k € | -24.0% | 94,0 k € | +14.1% | 82,4 k € | +18.7% | 69,4 k € | -47.9% | 133,2 k € | |
| Operating profit | 157,2 k € | +6.0% | 148,4 k € | +13.4% | 130,9 k € | +3.3% | 126,7 k € | +104.3% | 62,0 k € | -37.9% | 99,8 k € | +33.3% | 74,9 k € | -10.1% | 83,3 k € | +0.6% | 82,8 k € | +19.0% | 69,6 k € | -24.5% | 92,2 k € | +47.1% | 62,7 k € | -24.4% | 82,9 k € | +17.9% | 70,3 k € | +18.8% | 59,2 k € | -51.0% | 120,7 k € | |
| Profit/loss | 57,7 k € | -8.8% | 63,3 k € | +25.6% | 50,4 k € | +31.8% | 38,2 k € | -11.6% | 43,2 k € | +52.0% | 28,4 k € | +855.2% | -3,8 k € | -118.9% | 20,0 k € | -65.1% | 57,3 k € | +16.4% | 49,2 k € | -18.0% | 60,0 k € | +42.6% | 42,1 k € | -25.7% | 56,6 k € | +17.3% | 48,3 k € | +20.9% | 39,9 k € | -48.7% | 77,8 k € | |
| Equity | 267,0 k € | +14.1% | 234,1 k € | +37.0% | 170,8 k € | +22.2% | 139,8 k € | +37.6% | 101,5 k € | +74.1% | 58,3 k € | +95.3% | 29,9 k € | -11.2% | 33,6 k € | +135.2% | 14,3 k € | -77.5% | 63,6 k € | +340.8% | 14,4 k € | -74.4% | 56,4 k € | +293.3% | 14,3 k € | -85.9% | 101,8 k € | +90.2% | 53,5 k € | +252.6% | 15,2 k € | |
| Total assets | 323,2 k € | +16.3% | 278,1 k € | +13.5% | 245,0 k € | +9.2% | 224,4 k € | +87.7% | 119,5 k € | -1.4% | 121,2 k € | +38.8% | 87,3 k € | +1.6% | 85,9 k € | -52.1% | 179,4 k € | +160.1% | 69,0 k € | -47.0% | 130,1 k € | +115.9% | 60,3 k € | -66.7% | 180,9 k € | +25.9% | 143,7 k € | +58.7% | 90,5 k € | -30.8% | 130,8 k € | |
| Cash | 149,8 k € | +42.3% | 105,3 k € | +31.5% | 80,0 k € | -13.2% | 92,2 k € | +54.4% | 59,7 k € | -23.6% | 78,2 k € | +86.2% | 42,0 k € | +83.0% | 22,9 k € | -47.7% | 43,9 k € | +470.2% | 7,7 k € | -91.5% | 90,8 k € | +130.7% | 39,4 k € | -48.7% | 76,8 k € | -4.0% | 80,0 k € | +71.4% | 46,7 k € | +16.0% | 40,2 k € | |
| Debts | 56,3 k € | +27.9% | 44,0 k € | -40.7% | 74,2 k € | -12.3% | 84,6 k € | +370.4% | 18,0 k € | -71.4% | 62,9 k € | +9.5% | 57,4 k € | +9.9% | 52,3 k € | -68.3% | 165,1 k € | +2995.6% | 5,3 k € | -95.4% | 115,7 k € | +2905.2% | 3,8 k € | -97.7% | 166,6 k € | +297.1% | 41,9 k € | +13.2% | 37,0 k € | -68.0% | 115,6 k € | |
Private limited company · Soignies · incorporated on 27/11/2008
Private limited company profitable and well capitalised. Cash position rising (+42.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
SOCIETE MEDICALE LANDO ARMEL is a Private limited company incorporated in 2008. Its main activity is: Hospital activities. Its registered office is in Soignies.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette